MDGL
Madrigal Pharmaceuticals Inc
513.20$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.68 | 2.86 | 4.71 | 6.21 | 9.58 | 12.78 | 14.31 | 10.72 | 12.50 | 44.05 | |
| 0.01 | 0.01 | 0.01 | 0.03 | 0.10 | 0.16 | 0.20 | 0.41 | 0.81 | 1.09 | 0.92 | 1.37 | 3.75 | |
| -0.01 | -0.01 | -0.01 | 0.65 | 2.76 | 4.55 | 6.01 | 9.17 | 11.97 | 13.22 | 9.80 | 11.13 | 40.30 | |
| 3.84 | 3.57 | 3.56 | 3.32 | 3.16 | 1.17 | 2.00 | 2.44 | 7.74 | 5.18 | 3.74 | 3.13 | 16.82 | |
| 1.49 | 2.35 | 4.04 | 4.93 | 4.95 | 13.40 | 7.60 | 7.97 | 9.30 | 9.32 | 9.25 | 9.93 | 33.49 | |
| 5.33 | 5.93 | 7.60 | 8.25 | 8.11 | 7.61 | 9.60 | 11.30 | 17.04 | 15.88 | 12.99 | 13.06 | 51.37 | |
| -5.33 | -5.93 | -7.60 | -7.59 | -5.35 | -3.06 | -3.59 | -2.13 | -5.07 | -2.66 | -3.19 | -1.93 | -11.07 | |
| 0.19 | 0.20 | 0.19 | 0.17 | 0.17 | 0.16 | 0.15 | 0.15 | 0.33 | 0.37 | 0.27 | 0.27 | 1.08 | |
| -5.34 | -5.68 | -7.38 | -7.10 | -4.92 | -2.71 | -3.32 | -1.90 | -5.08 | -2.61 | -3.25 | -1.99 | -11.15 | |
| -0.01 | 0.00 | 0.01 | – | -0.01 | – | – | – | – | – | – | – | – | |
| -5.34 | -5.68 | -7.38 | -7.10 | -4.92 | -2.71 | -3.32 | -1.90 | -5.08 | -2.61 | -3.25 | -1.99 | -11.15 | |
| -5.15 | -5.47 | -7.18 | -6.92 | -4.74 | -2.53 | -3.15 | -1.74 | -4.73 | -2.22 | -2.97 | -1.93 | -10.25 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.